A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses

Clinical trial NCT07330674 · RECRUITING

Trial details

NCT number: NCT07330674
Sponsor: Aptabio Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Age Related Macular Degeneration (ARMD)AMD - Age-Related Macular Degeneration

Start date: 2026-02-01
Primary completion: 2027-11-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.